{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:46:11Z","timestamp":1792788371034,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Contract of Nanning Scientific Research and Technology Development Program","award":["No. KY01050033424003"],"award-info":[{"award-number":["No. KY01050033424003"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 31502079; No. 32360902"],"award-info":[{"award-number":["No. 31502079; No. 32360902"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Guangxi Natural Science Foundation of China","award":["No. 2021GXNSFAA196058"],"award-info":[{"award-number":["No. 2021GXNSFAA196058"]}]},{"name":"the Guangxi Special Program on Talent Training for Agriculture and Rural Revitalization","award":["No. GXQNTJ242115"],"award-info":[{"award-number":["No. GXQNTJ242115"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Edema disease (ED), a fatal disease in weaned piglets, is caused by Shiga toxin-producing\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    (STEC). The increasing emergence of antibiotic-resistant\n                    <jats:italic>E. coli<\/jats:italic>\n                    strains has necessitated the exploration of alternatives such as bacteriophage therapy. Using a porcine model, this study evaluated the prophylactic effect of bacteriophage P-GXEC-L2P5 administered by oral gavage against ED. The novel phage P-GXEC-L2P5 was isolated using a multidrug-resistant (MDR) STEC strain GXEC-STL2 as the host. P-GXEC-L2P5 was identified as a member of\n                    <jats:italic>Caudoviricetes<\/jats:italic>\n                    ,\n                    <jats:italic>Dhillonvirus<\/jats:italic>\n                    , with an 88,607 base pair (bp) genome, and it possessed a short latent period (10 min), moderate pH stability (5\u201310), and appropriate thermal tolerance (4\u201360 \u2103). Piglets pretreated with P-GXEC-L2P5 showed no apparent clinical signs (e.g., eyelid edema or neurological symptoms) after challenge with GXEC-STL2. B-scan ultrasound revealed no significant hydronephrosis. Necropsy showed only mild intestinal congestion, with no other gross pathological lesions noted. Histopathology demonstrated no significant differences in features compared with noninfected controls. Phage treatment significantly reduced fecal STEC shedding (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; 0.05) and significantly decreased Stx2e concentrations in serum, cerebral cortex, kidney, and small intestine (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; 0.01). The messenger RNA (mRNA) expression of Gb4 (Stx2e receptor) was significantly lower in these tissues (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; 0.05). Concurrently, vascular endothelial cells exhibited increased FITC-labeled wheat germ agglutinin (FITC-WGA) fluorescence intensity and increased mRNA expression of endothelial integrity factors (connexin43, vinculin, and zonula occludens-1;\n                    <jats:italic>P<\/jats:italic>\n                    &lt; 0.05). In addition, phage treatment preserved jejunal microbiota diversity and abundance. In conclusion, P-GXEC-L2P5 effectively prevented STEC-induced ED by reducing STEC load and Stx2e levels, while mitigating increased vascular permeability.\n                  <\/jats:p>","DOI":"10.1186\/s13567-025-01683-w","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:49:23Z","timestamp":1765968563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting STEC-induced edema disease in weaned piglets: prophylactic oral phage P-GXEC-L2P5 attenuates bacterial colonization, toxin production, and endothelial damage"],"prefix":"10.1186","volume":"57","author":[{"given":"Runwen","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"1683_CR1","first-page":"7","volume":"9","author":"F Tabaran","year":"2019","unstructured":"Tabaran F, Tabaran A (2019) Edema disease of swine: a review of the pathogenesis. Porcine Res 9:7\u201314","journal-title":"Porcine Res"},{"key":"1683_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.toxicon.2018.04.019","volume":"148","author":"NA Casanova","year":"2018","unstructured":"Casanova NA, Redondo LM, Dailoff GC, Arenas D, Fern\u00e1ndez Miyakawa ME (2018) Overview of the role of Shiga toxins in porcine edema disease pathogenesis. Toxicon 148:149\u2013154","journal-title":"Toxicon"},{"key":"1683_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3390\/toxins12050345","volume":"12","author":"C Menge","year":"2020","unstructured":"Menge C (2020) Molecular biology of Escherichia coli Shiga toxins\u2019 effects on mammalian cells. Toxins 12:345","journal-title":"Toxins"},{"key":"1683_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12040682","volume":"12","author":"MM Barros","year":"2023","unstructured":"Barros MM, Castro J, Ara\u00fajo D, Campos AM, Oliveira R, Silva S, Outor-Monteiro D, Almeida C (2023) Swine colibacillosis: global epidemiologic and antimicrobial scenario. Antibiotics 12:682","journal-title":"Antibiotics"},{"key":"1683_CR5","doi-asserted-by":"publisher","first-page":"1244026","DOI":"10.3389\/fmicb.2023.1244026","volume":"14","author":"J Hu","year":"2023","unstructured":"Hu J, Li J, Huang X, Xia J, Cui M, Huang Y, Wen Y, Xie Y, Zhao Q, Cao S, Zou L, Han X (2023) Genomic traits of multidrug resistant enterotoxigenic Escherichia coli isolates from diarrheic pigs. Front Microbiol 14:1244026","journal-title":"Front Microbiol"},{"key":"1683_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.981207","volume":"9","author":"J Castro","year":"2022","unstructured":"Castro J, Barros MM, Ara\u00fajo D, Campos AM, Oliveira R, Silva S, Almeida C (2022) Swine enteric colibacillosis: current treatment avenues and future directions. Front Vet Sci 9:981207","journal-title":"Front Vet Sci"},{"key":"1683_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijantimicag.2018.09.004","volume":"53","author":"A Kakasis","year":"2019","unstructured":"Kakasis A, Panitsa G (2019) Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review. Int J Antimicrob Agents 53:16\u201321","journal-title":"Int J Antimicrob Agents"},{"key":"1683_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12040751","volume":"12","author":"K Diallo","year":"2023","unstructured":"Diallo K, Dublanchet A (2023) A century of clinical use of phages: a literature review. Antibiotics 12:751","journal-title":"Antibiotics"},{"key":"1683_CR9","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1016\/S1473-3099(21)00612-5","volume":"22","author":"S Uyttebroek","year":"2022","unstructured":"Uyttebroek S, Chen B, Onsea J, Ruythooren F, Debaveye Y, Devolder D, Spriet I, Depypere M, Wagemans J, Lavigne R, Pirnay JP, Merabishvili M, De Munter P, Peetermans WE, Dupont L, Van Gerven L, Metsemakers WJ (2022) Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review. Lancet Infect Dis 22:e208\u2013e220","journal-title":"Lancet Infect Dis"},{"key":"1683_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","volume":"186","author":"SA Strathdee","year":"2023","unstructured":"Strathdee SA, Hatfull GF, Mutalik VK, Schooley RT (2023) Phage therapy: from biological mechanisms to future directions. Cell 186:17\u201331","journal-title":"Cell"},{"key":"1683_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics7010017","volume":"7","author":"MJ Love","year":"2018","unstructured":"Love MJ, Bhandari D, Dobson RCJ, Billington C (2018) Potential for bacteriophage endolysins to supplement or replace antibiotics in food production and clinical care. Antibiotics 7:17","journal-title":"Antibiotics"},{"key":"1683_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/jas\/skab157","volume":"99","author":"K Desiree","year":"2021","unstructured":"Desiree K, Mosimann S, Ebner P (2021) Efficacy of phage therapy in pigs: systematic review and meta-analysis. J Anim Sci 99:skab157","journal-title":"J Anim Sci"},{"key":"1683_CR13","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3390\/ani15121713","volume":"15","author":"J Chen","year":"2025","unstructured":"Chen J, Han J, Yang Z, Zhou W, He Y, Chen X, Li X, Zou T, You J (2025) Bacteriophages as potential anti-pathogenic agents for intestinal health of weaned piglets in the post-antibiotic era: an updated review. Animals 15:1713","journal-title":"Animals"},{"key":"1683_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12917-023-03724-y","volume":"19","author":"X Mao","year":"2023","unstructured":"Mao X, Wu Y, Ma R, Li L, Wang L, Tan Y, Li Z, Liu H, Han K, Cao Y, Li Y, Peng H, Li X, Hu C, Wang X (2023) Oral phage therapy with microencapsulated phage A221 against Escherichia coli infections in weaned piglets. BMC Vet Res 19:165","journal-title":"BMC Vet Res"},{"key":"1683_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2023.109923","volume":"288","author":"L Li","year":"2024","unstructured":"Li L, Han K, Mao X, Wang L, Cao Y, Li Z, Wu Y, Tan Y, Shi Y, Zhang L, Liu H, Li Y, Peng H, Li X, Hu C, Wang X (2024) Oral phages prophylaxis against mixed Escherichia coli O157:H7 and Salmonella typhimurium infections in weaned piglets. Vet Microbiol 288:109923","journal-title":"Vet Microbiol"},{"key":"1683_CR16","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41598-022-04861-4","volume":"12","author":"N Kim","year":"2022","unstructured":"Kim N, Gu MJ, Kye YC, Ju YJ, Hong R, Ju DB, Pyung YJ, Han SH, Park BC, Yun CH (2022) Bacteriophage EK99P-1 alleviates enterotoxigenic Escherichia coli K99-induced barrier dysfunction and inflammation. Sci Rep 12:941","journal-title":"Sci Rep"},{"key":"1683_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2021.623899","volume":"8","author":"Y Zeng","year":"2021","unstructured":"Zeng Y, Wang Z, Zou T, Chen J, Li G, Zheng L, Li S, You J (2021) Bacteriophage as an alternative to antibiotics promotes growth performance by regulating intestinal inflammation, intestinal barrier function and gut microbiota in weaned piglets. Front Vet Sci 8:623899","journal-title":"Front Vet Sci"},{"key":"1683_CR18","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11262-022-01916-6","volume":"58","author":"L Li","year":"2022","unstructured":"Li L, Wu Y, Ma D, Zhou Y, Wang L, Han K, Cao Y, Wang X (2022) Isolation and characterization of a novel Escherichia coli phage Kayfunavirus ZH4. Virus Genes 58:448\u2013457","journal-title":"Virus Genes"},{"key":"1683_CR19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3390\/v14020286","volume":"14","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Li L, Han K, Wang L, Cao Y, Ma D, Wang X (2022) A polyvalent broad-spectrum Escherichia phage Tequatrovirus EP01 capable of controlling Salmonella and Escherichia coli contamination in foods. Viruses 14:286","journal-title":"Viruses"},{"key":"1683_CR20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s11262-023-01966-4","volume":"59","author":"K Han","year":"2023","unstructured":"Han K, Mao X, Liu H, Wu Y, Tan Y, Li Z, Ma R, Li Y, Li L, Wang L, Shi Y, Cao Y, Peng H, Li X, Wang X (2023) Characterization and genome analysis of a novel phage Kayfunavirus TM1. Virus Genes 59:302\u2013311","journal-title":"Virus Genes"},{"key":"1683_CR21","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1292\/jvms.67.1167","volume":"67","author":"T Tsukahara","year":"2005","unstructured":"Tsukahara T, Nakanishi N, Nakayama K, Matsubara N, Ushida K (2005) Experimental infection of enterotoxemic Escherichia coli associated with porcine edema disease and its pathologic characteristics in the intestine. J Vet Med Sci 67:1167\u20131171","journal-title":"J Vet Med Sci"},{"key":"1683_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12112588","volume":"12","author":"S Srirungruang","year":"2022","unstructured":"Srirungruang S, Mahajindawong B, Nimitpanya P, Bunkasem U, Ayuyoe P, Nuchprayoon S, Sanprasert V (2022) Comparative study of DNA extraction methods for the PCR detection of intestinal parasites in human stool samples. Diagnostics 12:2588","journal-title":"Diagnostics"},{"key":"1683_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.tvjl.2018.12.015","volume":"244","author":"M Brilhante","year":"2019","unstructured":"Brilhante M, Perreten V, Don\u00e0 V (2019) Multidrug resistance and multivirulence plasmids in enterotoxigenic and hybrid Shiga toxin-producing\/enterotoxigenic Escherichia coli isolated from diarrheic pigs in Switzerland. Vet J 244:60\u201368","journal-title":"Vet J"},{"key":"1683_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-1-0716-1339-9_2","volume":"2291","author":"SA Barth","year":"2021","unstructured":"Barth SA, Bauerfeind R, Berens C, Menge C (2021) Shiga toxin-producing E. coli in animals: detection, characterization, and virulence assessment. Methods Mol Biol 2291:19\u201386","journal-title":"Methods Mol Biol"},{"key":"1683_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2020.545818","volume":"7","author":"V Baldo","year":"2020","unstructured":"Baldo V, Salogni C, Giovannini S, D\u2019Incau M, Boniotti MB, Birbes L, Pitozzi A, Formenti N, Grassi A, Pasquali P, Alborali GL (2020) Pathogenicity of Shiga toxin type 2e Escherichia coli in pig colibacillosis. Front Vet Sci 7:545818","journal-title":"Front Vet Sci"},{"key":"1683_CR26","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1111\/asj.13292","volume":"90","author":"T Hamabata","year":"2019","unstructured":"Hamabata T, Sato T, Takita E, Matsui T, Imaoka T, Nakanishi N, Nakayama K, Tsukahara T, Sawada K (2019) Shiga toxin 2eB-transgenic lettuce vaccine is effective in protecting weaned piglets from edema disease caused by Shiga toxin-producing Escherichia coli infection. Anim Sci J 90:1460\u20131467","journal-title":"Anim Sci J"},{"key":"1683_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12917-017-0962-2","volume":"13","author":"G Won","year":"2017","unstructured":"Won G, Kim TH, Lee JH (2017) A novel Salmonella strain inactivated by a regulated autolysis system and expressing the B subunit of Shiga toxin 2e efficiently elicits immune responses and confers protection against virulent Stx2e-producing Escherichia coli. BMC Vet Res 13:40","journal-title":"BMC Vet Res"},{"key":"1683_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/toxins11040212","volume":"11","author":"M-S Lee","year":"2019","unstructured":"Lee M-S, Tesh VL (2019) Roles of Shiga toxins in immunopathology. Toxins 11:212","journal-title":"Toxins"},{"key":"1683_CR29","doi-asserted-by":"publisher","first-page":"16623","DOI":"10.1038\/s41598-019-52900-4","volume":"9","author":"T Delvaeye","year":"2019","unstructured":"Delvaeye T, De Smet MAJ, Verwaerde S, Decrock E, Czekaj A, Vandenbroucke RE, Lemeire K, Gon\u00e7alves A, Declercq W, Vandenabeele P, Krysko DV, Leybaert L (2019) Blocking connexin43 hemichannels protects mice against tumour necrosis factor-induced inflammatory shock. Sci Rep 9:16623","journal-title":"Sci Rep"},{"key":"1683_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.pbiomolbio.2025.01.004","volume":"195","author":"J Li","year":"2025","unstructured":"Li J, Wang W, Lin Z, Liu Z, Zhang R, Li R, Zhang J, Zheng Y, Qin D, Wu Y, Liu Y (2025) Vinculin: a new target for the diagnosis and treatment of disease. Prog Biophys Mol Biol 195:157\u2013166","journal-title":"Prog Biophys Mol Biol"},{"key":"1683_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/ibd\/izae232","volume":"31","author":"P Arumugam","year":"2025","unstructured":"Arumugam P, Saha K, Nighot P (2025) Intestinal epithelial tight junction barrier regulation by novel pathways. Inflamm Bowel Dis 31:259\u2013271","journal-title":"Inflamm Bowel Dis"},{"key":"1683_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fcimb.2018.00025","volume":"8","author":"F Gigliucci","year":"2018","unstructured":"Gigliucci F, von Meijenfeldt FAB, Knijn A, Michelacci V, Scavia G, Minelli F, Dutilh BE, Ahmad HM, Raangs GC, Friedrich AW, Rossen JWA, Morabito S (2018) Metagenomic characterization of the human intestinal microbiota in fecal samples from STEC-infected patients. Front Cell Infect Microbiol 8:25","journal-title":"Front Cell Infect Microbiol"},{"key":"1683_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40104-023-00869-6","volume":"14","author":"Y Choi","year":"2023","unstructured":"Choi Y, Hosseindoust A, Ha SH, Kim J, Min Y, Jeong Y, Mun J, Sa S, Kim J (2023) Effects of dietary supplementation of bacteriophage cocktail on health status of weanling pigs in a non-sanitary environment. J Anim Sci Biotechnol 14:64","journal-title":"J Anim Sci Biotechnol"},{"key":"1683_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/v11010018","volume":"11","author":"O Patey","year":"2018","unstructured":"Patey O, McCallin S, Mazure H, Liddle M, Smithyman A, Dublanchet A (2018) Clinical indications and compassionate use of phage therapy: personal experience and literature review with a focus on osteoarticular infections. Viruses 11:18","journal-title":"Viruses"},{"key":"1683_CR35","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1038\/s41467-024-47192-w","volume":"15","author":"JD Berkson","year":"2024","unstructured":"Berkson JD, Wate CE, Allen GB, Schubert AM, Dunbar KE, Coryell MP, Sava RL, Gao Y, Hastie JL, Smith EM, Kenneally CR, Zimmermann SK, Carlson PE Jr (2024) Phage-specific immunity impairs efficacy of bacteriophage targeting vancomycin resistant Enterococcus in a murine model. Nat Commun 15:2993","journal-title":"Nat Commun"},{"key":"1683_CR36","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/postgradmedj-2022-141546","volume":"99","author":"TY Au","year":"2023","unstructured":"Au TY, Assavarittirong C (2023) Combating antimicrobial resistance: an evidence-based overview of bacteriophage therapy. Postgrad Med J 99:654\u2013660","journal-title":"Postgrad Med J"},{"key":"1683_CR37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12223-020-00835-z","volume":"66","author":"M \u0141usiak-Szelachowska","year":"2021","unstructured":"\u0141usiak-Szelachowska M, Mi\u0119dzybrodzki R, Fortuna W, Borysowski J, G\u00f3rski A (2021) Anti-phage serum antibody responses and the outcome of phage therapy. Folia Microbiol 66:127\u2013131","journal-title":"Folia Microbiol"},{"key":"1683_CR38","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.3390\/ijms23094577","volume":"23","author":"C Aranaga","year":"2022","unstructured":"Aranaga C, Pantoja LD, Mart\u00ednez EA, Falco A (2022) Phage therapy in the era of multidrug resistance in bacteria: a systematic review. Int J Mol Sci 23:4577","journal-title":"Int J Mol Sci"},{"key":"1683_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2024.110330","volume":"300","author":"Y Wu","year":"2025","unstructured":"Wu Y, Zhang L, Zheng H, Huang W, Zhang X, Ji W, Ma R, Mao X, Huang Y, Liu X, Zeng J, Guo S, Cheng Z, Wang T, Wang M, Wang W, Huang J, Lu X, Li L, Li Y, Bai X, Wei Y, Li X, Wang X (2025) Oral bacteriophage therapy effectively prevent and control of Clostridium perfringens type c infections in newborn piglets. Vet Microbiol 300:110330","journal-title":"Vet Microbiol"},{"key":"1683_CR40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/jsfa.11505","volume":"102","author":"J Li","year":"2022","unstructured":"Li J, Zhao F, Zhan W, Li Z, Zou L, Zhao Q (2022) Challenges for the application of bacteriophages as effective antibacterial agents in the food industry. J Sci Food Agric 102:461\u2013471","journal-title":"J Sci Food Agric"},{"key":"1683_CR41","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/v12070742","volume":"12","author":"EA W\u00f3jcik","year":"2020","unstructured":"W\u00f3jcik EA, Sta\u0144czyk M, Wojtasik A, Kowalska JD, Nowakowska M, \u0141ukasiak M, Bartnicka M, Kazimierczak J, Dastych J (2020) Comprehensive evaluation of the safety and efficacy of BAFASAL(\u00ae) bacteriophage preparation for the reduction of Salmonella in the food chain. Viruses 12:742","journal-title":"Viruses"},{"key":"1683_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2025.128107","volume":"295","author":"H Zou","year":"2025","unstructured":"Zou H, Huang X, Xiao W, He H, Liu S, Zeng H (2025) Recent advancements in bacterial anti-phage strategies and the underlying mechanisms altering susceptibility to antibiotics. Microbiol Res 295:128107","journal-title":"Microbiol Res"},{"key":"1683_CR43","doi-asserted-by":"publisher","first-page":"10771","DOI":"10.1073\/pnas.1305923110","volume":"110","author":"JJ Barr","year":"2013","unstructured":"Barr JJ, Auro R, Furlan M, Whiteson KL, Erb ML, Pogliano J, Stotland A, Wolkowicz R, Cutting AS, Doran KS, Salamon P, Youle M, Rohwer F (2013) Bacteriophage adhering to mucus provide a non\u2013host-derived immunity. Proc Natl Acad Sci USA 110:10771\u201310776","journal-title":"Proc Natl Acad Sci USA"},{"key":"1683_CR44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cis.2017.05.014","volume":"249","author":"DJ Malik","year":"2017","unstructured":"Malik DJ, Sokolov IJ, Vinner GK, Mancuso F, Cinquerrui S, Vladisavljevic GT, Clokie MRJ, Garton NJ, Stapley AGF, Kirpichnikova A (2017) Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Adv Colloid Interface Sci 249:100\u2013133","journal-title":"Adv Colloid Interface Sci"}],"container-title":["Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-025-01683-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13567-025-01683-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-025-01683-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T13:02:43Z","timestamp":1769000563000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13567-025-01683-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1683"],"URL":"https:\/\/doi.org\/10.1186\/s13567-025-01683-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6754528\/v1","asserted-by":"object"}]},"ISSN":["1297-9716"],"issn-type":[{"value":"1297-9716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of the experiments were performed according to the guidelines of the regional Animal Ethics Committee and the rules for experimental animals of Guangxi University (GXU-2024-071). All methods were carried out in compliance with the revised Animals (Scientific Procedures) Act 1986 of the UK, as well as relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}